Ductal Carcinoma In Situ of the Breast: A Review of Diagnosis, Treatment and Outcome in a Hospital-based Norwegian Series

Authors

  • Hege Wang From the Cancer Registry of Norway, Montebello, Norway
  • Peter W. Jebsen Departments of Pathology, Norway
  • Rolf Kåresen Surgery, Ullevål Hospital, Oslo, Norway
  • Steinar Ø. Thoresen From the Cancer Registry of Norway, Montebello, Norway

DOI:

https://doi.org/10.1080/028418600430662

Abstract

Between 1980 and 1994, 71 women with histologically proven ductal carcinoma in situ (DCIS) were diagnosed at Ullevål Hospital; bilateral tumours were found in two patients. Surgical treatment was mastectomy (42 lesions) or local excision (31 lesions). Median follow-up time was 7.2 years. Ten patients experienced a local recurrence, seven of which were invasive carcinomas. The actuarial 5-year local recurrence rate was 22% after local excision. A multivariate analysis found that tumour size was the only factor that predicted local recurrence after local excision. An analysis of relative survival in a nation-wide material of 832 DCIS patients in the period 1980 to 1994 demonstrates that relative survival after a DCIS diagnosis is almost 100%, irrespective of surgical treatment of the initial lesion.

Downloads

Download data is not yet available.

Downloads

Published

2000-01-01

How to Cite

Wang, H., Jebsen, P. W., Kåresen, R., & Thoresen, S. Ø. (2000). Ductal Carcinoma In Situ of the Breast: A Review of Diagnosis, Treatment and Outcome in a Hospital-based Norwegian Series. Acta Oncologica, 39(2), 131–134. https://doi.org/10.1080/028418600430662

Issue

Vol. 39 No. 2 (2000): Acta Oncologica

Section

Articles